Sponsor

Endogenex, Inc.

Clinical research sponsor

Published trials6

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

6 shown

Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 DiabetesNCT07768631 · lead sponsor · 2027-01-01

NOT_YET_RECRUITING

Continued Access to the Endogenex System for Participants in the ReCET Pivotal StudyNCT07197788 · lead sponsor · 2026-09-01

ENROLLING_BY_INVITATION

Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)NCT07197775 · lead sponsor · 2026-03-11

ENROLLING_BY_INVITATION

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II DiabetesNCT06267391 · lead sponsor · 2024-05-01

ACTIVE_NOT_RECRUITING

Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II DiabetesNCT05014204 · lead sponsor · 2021-10-29

COMPLETED

Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II DiabetesNCT04725890 · lead sponsor · 2021-04-20

COMPLETED

Sponsor roles

lead sponsor6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.